Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

National Healthcare Properties (HLTC) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for National Healthcare Properties (HLTC) over the last 13 years, with Q3 2025 value amounting to $1.3 million.

  • National Healthcare Properties' Share-based Compensation rose 77124.18% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year increase of 12574.14%. This contributed to the annual value of $613000.0 for FY2024, which is 3329.71% down from last year.
  • As of Q3 2025, National Healthcare Properties' Share-based Compensation stood at $1.3 million, which was up 77124.18% from $570000.0 recorded in Q2 2025.
  • National Healthcare Properties' Share-based Compensation's 5-year high stood at $1.3 million during Q3 2025, with a 5-year trough of $153000.0 in Q3 2024.
  • Moreover, its 5-year median value for Share-based Compensation was $291000.0 (2022), whereas its average is $349941.2.
  • Its Share-based Compensation has fluctuated over the past 5 years, first plummeted by 3318.78% in 2024, then surged by 77124.18% in 2025.
  • National Healthcare Properties' Share-based Compensation (Quarter) stood at $333000.0 in 2021, then tumbled by 30.93% to $230000.0 in 2022, then changed by 0.0% to $230000.0 in 2023, then plummeted by 33.48% to $153000.0 in 2024, then surged by 771.24% to $1.3 million in 2025.
  • Its Share-based Compensation stands at $1.3 million for Q3 2025, versus $570000.0 for Q2 2025 and $153000.0 for Q3 2024.